The PCMA Business Forum was a two-day event offering invaluable networking and education for individuals involved in specialty drug benefit management and patient management including executives from the largest specialty pharmacies and PBMs, as well as from drug and biotech manufacturers, consulting companies, and other important stakeholders.
PCMA Business Forum 2023 Agenda
7:00 am - 7:00 pm | Registration Open Grande Registration Desk | |
7:00 am - 6:30 pm | Private Meeting Rooms Open | |
8:00 am - 9:15 am | Diversity, Inclusion, and Women’s Leadership Networking Breakfast and Session: Diversity of Thought Palazzo Ballroom
Initiative Co-chairs: Harold Carter, Senior Vice President, Pharma Trade Relations, Express Scripts Jane Thompson, Head of US Account Management, UCB Guest Speaker: Latesha Byrd, CEO, Talent Development Advisor, PERFEQTA Panel: Tonya Adams, Head of Diversity and Inclusion, UCB Lei Ding, Senior Vice President, Market Access & Commercial Capabilities, Astellas Lilian Ndehi-Rice Associate Vice President, Pharmacy, Clinical, and Specialty Strategies, Humana, Inc. | |
8:00 am - 9:15 am | Networking Breakfast Mediterranean Porte-Cochere | |
9:30 am - 12:00 pm | MORNING EDUCATIONAL SESSIONS Mediterranean Ballroom
9:30 a.m. – 10:00 a.m. PCMA Leadership Welcome JC Scott, President & Chief Executive Officer, PCMA Adam Kautzner, President, Express Scripts, and PCMA Chairman of the Board 10:00 a.m. – 10:45 a.m. Alex Hindman, Vice President, Industry Relations, OptumRx Chris Stewart, Vice President, Manufacturer Trade Relations and Operations, Humana Moderator: Ian Spatz, National Advisor, Manatt, Phelps & Phillips
10:45 a.m. – 11:30 a.m. Hot Topics and Trends Impacting Today’s PBM and Pharma Business Strategies Steve Albers, Senior Vice President, Market Access & Public Affairs, Novo Nordisk Harold Carter, Senior Vice President, Pharma Trade Relations, Express Scripts Rick Dudek, Senior Vice President, US Payer & Channel Access, Pfizer Bethanie Stein, Senior Vice President, Pharmacy Benefit Manager Services, Humana Moderator: Ian Spatz, National Advisor, Manatt, Phelps & Phillips
11:30 a.m. – 12:00 p.m. Advanced Analytics to Identify Gaps in Care – Daniel Knecht, Vice President & Chief Clinical Innovation Officer, CVS Caremark Using advanced analytics to identify individualized interventions not only reduces unnecessary spending but can also improve outcomes throughout a patient’s unique condition journey. Technology can help patients and their care teams gauge the efficacy of their care and how they’re managing their health overall. Utilizing a comprehensive patient view and a proactive monitoring approach, we can recommend targeted clinical interventions to patients that may otherwise be experiencing challenges with treatment. By capturing metrics specific to a patient’s symptoms and functional status, we can not only optimize their individual treatment plan, but we can also apply machine learning to gather insights that could apply to – and improve care for – a much larger patient population with the same condition. By attending this session, you should be able to:
| |
12:15 pm - 1:30 pm | Networking Lunch & Member Company Lunch Receptions Only pharmaceutical manufacturing companies will be permitted into the Member Company lunches
Ascent Health: DaVinci Lawn A Express Scripts: Valencia Lawn A Humana: Valencia Lawn B Prime/Magellan: DaVinci Lawn B | |
1:30 pm - 3:00 pm | AFTERNOON EDUCATIONAL SESSIONS Palazzo Ballroom
1:30 p.m. – 2:00 p.m. The Rise of Alternative Funding Programs and Challenges Ahead Alternative funding programs are a recent concept in the self-insured market where high cost drugs are “carved out” of the employer’s coverage to its members, thereby making the member “uninsured” and in theory eligible for needs based patient assistance program coverage. This practice is not short on pitfalls for patients, payers and many others in the business of pharmaceutical care. By attending this session, you should be able to:
2:00 p.m. – 2:30 p.m. Using Social Determinant Data to Optimize Medication Adherence and Overall Health Medication adherence has been a long-standing challenge in healthcare. While it is easily identified as a root cause for many poor health outcomes, it’s not easily solved for. Social determinants of Health data offers a unique opportunity to tap into underlying factors that can be impacting the ability and motivation of patients to take their medications. Kodi will help highlight the rising demand for healthcare to become more creative and thoughtful in how it leverages data to help solve one of healthcare’s biggest challenges. By attending this session you should be able to:
2:30 p.m. – 3:00 p.m. Doug Long, Vice President Industry Relations, IQVIA Doug Long is a regular and popular presenter at PCMA conferences, and for good reason. His presentations always offer an insightful analysis of the most up-to-date industry data and highlight pharmacy trends, issues, and forecasts. His presentation this year reflects many compelling and unique trends being seen in the post-pandemic healthcare environment. By attending this session, you should be able to:
| |
6:00 pm - 8:00 pm | Cocktail and Dinner Reception with Live Music Valencia Lawn |
7:00 am – 4:00 pm | Registration Open Grande Registration Desk | |
7:00 am - 5:30 pm | Private Meeting Rooms Open | |
8:00 am - 9:15 am | Emerging Biopharmaceutical Company Networking Breakfast and Session: Unlocking the Value of Small and Emerging Pharmaceutical Manufacturer Relationships with PBM’s Palazzo Ballroom
Ed Adamcik, President, Ascent Health Services Jim Clement, Partner, Coeus Consulting Group Justin Lester, Vice President, General Manager, Emisar Moderator: Tom Knox, President, Fathom Healthcare Solutions | |
8:00 am - 9:15 am | Networking Breakfast Mediterranean Porte-Cochere | |
9:15 am - 12:15 pm | EDUCATIONAL SESSIONS Mediterranean Ballroom
9:30 a.m. – 10:00 a.m. Reducing Cost-Sharing in Part D: PBM Perspectives in Managing Care Tim Dube, Vice President for Regulatory Affairs, PCMA Amanda Karp, Assistant General Counsel, Elixir Rx Solutions Moderator: Ian Spatz, National Advisor, Manatt, Phelps & Phillips
10:00 a.m. – 10:45 a.m. PBM Perspectives on New and Future Biosimilars Market Introductions Josh Fredell, Vice President & Head of PBM & Specialty Product Innovation, CVS Health Jamey Millar, Senior Vice President Industry Relations, OptumRx Moderator: Ian Spatz, National Advisor, Manatt, Phelps & Phillips
10:45 a.m. – 11:15 a.m. Clinical Support Programs to Achieve Clinical Efficacy: GLP1 drug class case study Jackie Todisco, Executive Director, Care Management, CVS Health, CVS Health The GLP1 drug class is one of the most discussed today, both within the pharmaceutical care, payment and delivery industry, and more broadly in the general public. These drugs represent a highly effective new therapy in the treatment of obesity. Many complexities exist in this new drug class. Ms. Todisco will unpack these complexities and discuss how PBMs are working to manage care and optimize clinical outcomes. By attending this session, you should be able to:
11:15 a.m. – 11:45 a.m. Beyond the PBM’s Core Functionality – Driving Market Access with Innovation Oron Stenesh, Vice President Product, Optum Rx PBMs are driving market access with innovation supporting pharmaceutical manufacturers, plan sponsors, plan members and consumers. In this session, you’ll hear how OptumRx thinks about the product development that enables that access. With product focus areas ranging from consumer affordability and price transparency to managing specialty drug costs, OptumRx is bringing market-leading solutions to the fore, answering today’s demands and preparing for tomorrow’s evolving marketplace needs. By attending this session, you should be able to:
11:45 a.m. – 12:15 p.m. Pharma 101 and Future Trends and Impacts Are you new or relatively new to the US pharmaceutical and pharmacy market? Have you reached the point of acronym overload? Or perhaps you know your corner of the pharma world but would like to see the entire market picture. Mr. Travis will provide a fast-paced overview of the major players and processes that drive the $500 billion US pharmaceutical market. His presentation will span the discovery of the atorvastatin molecule to the latest advances in gene therapy. By attending this session, you should be able to
| |
12:30 pm – 1:45 pm | Networking Lunch & Member Company Lunch Receptions Only pharmaceutical manufacturing companies will be permitted into the Member Company lunches
CVS Health: Valencia Lawn A MedImpact: DaVinci Lawn B OptumRx: DaVinci Lawn A PerformRx: Valencia Lawn B Zinc Health Services: DaVinci Lawn North | |
8:00 pm - 10:00 pm | Cocktail and Dessert Reception JW Lobby Lounge – Evr Bar Join your peers for dessert, cocktails, and conversation with colleagues at this after-dinner reception. |